With an educational background in electro-chemical engineering and strategic marketing, Jean-Michel brings vast business acumen and pharmaceutical experience to his role at AOP Health. Jean-Michel joins AOP Health from Toniq s.r.o., a venture capital firm based in Bratislava, Slovakia, focused on innovation in the life sciences sector, which he founded and served as CEO since 2022. Prior to this, he served as President & CEO of Nordic Pharma in the Netherlands following its merger with Amring International—a company he also founded and expanded through acquisitions in Lausanne, Switzerland. Previously, as Managing Director at Vestergaard, he led global operations in the Public Health division focusing on the fight against malaria, HIV and carbon emissions. Earlier in his career, Jean-Michel spent 15 years with Hoechst Marion Roussel (now part of Sanofi), and later with Bristol-Myers Squibb, holding various leadership roles in Finance and General Management across France, the UK, Italy, Austria, Central & Eastern Europe and the United States.
Over the course of his career, Jean-Michel has lived in 12 countries across Europe, the USA, Latin America, and Africa, and speaks 5 languages including his native French. Jean-Michel is a board member of various organizations and an active investor in life science start-ups and projects.
Jean-Michel Quinot, DI, MBA
Jean-Michel Quinot, DI, MBA, Chief Operating Officer, brings extensive international leadership experience in the pharmaceutical industry, with a strong track record of driving operations growth and fostering high-performing teams.
Jean-Michel Quinot, DI, MBA
At AOP Health, we strive to transform bold ideas into impactful solutions - supporting access to essential treatments for patients within an ever-changing healthcare landscape.